Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 11:18 ET | Source: Research and Markets

RAGE Inhibitor Pipeline Insight Report 2025 Analyzes RAGE Inhibitor Drugs, Key Players, and Development Activities

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "RAGE Inhibitor - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report is a comprehensive resource providing...
January 31, 2024 04:06 ET | Source: Research and Markets

Imutex's FLU-v Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032: Focus on United States,Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "FLU-v Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
January 30, 2024 10:59 ET | Source: Research and Markets

VBI-1901 Drug and Market Analysis Report 2023-2032: Mechanism of Action, Clinical Trials, Collaborations, and Market Projections for a Promising GBM Therapy

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "VBI-1901 Emerging Drug Insight and Market Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report provides an...
January 30, 2024 10:54 ET | Source: Research and Markets

MGB-BP-3 Drug and Market Analysis 2023-2032: A Promising Treatment for Clostridium Difficile Infection (CDI)

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MGB-BP-3 Emerging Drug Insight and Market Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report provides an...
January 30, 2024 10:51 ET | Source: Research and Markets

MPH966 (Alvelestat) Drug Insight with Market Projections to 2032: A Novel Therapy Under Development for Bronchiolitis Obliterans Syndrome (BOS)

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MPH966 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers an in-depth...
January 30, 2024 10:50 ET | Source: Research and Markets

MTG201 + Nivolumab Drug and Market Analysis 2023-2032: Sales Analytics, Clinical Assessment, SWOT Analysis, Emerging Competitors

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MTG201 + nivolumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides...
January 30, 2024 07:29 ET | Source: Research and Markets

Analysis of INOVIO's INO-5401 & INO-9012 and Regeneron & Sanofi's LIBTAYO (Cemiplimab) Treatment for Glioblastoma Multiforme (GBM): Drug Insights, Regulatory Landscape, and Market Forecast to 2032

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "INO-5401 + INO-9012 + LIBTAYO Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This...
January 30, 2024 07:19 ET | Source: Research and Markets

Analysis of AstraZeneca's IMFINZI (Durvalumab) for Treating Malignant Pleural Mesothelioma (MPM): Regulatory Landmarks, Market Expansion, Intellectual Property, Future Challenges - Forecast to 2032

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "IMFINZI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
January 30, 2024 06:50 ET | Source: Research and Markets

AV-GBM-1 Market Report 2023-2032: Drug Overview, Sales Analysis, SWOT Analysis, Emerging Competition and Future Prospects

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "AV-GBM-1 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This market forecast report...
January 30, 2024 06:47 ET | Source: Research and Markets

VXA-A1.1 Clinical Advances and Market Forecast to 2032: Drug Developments, Regulatory Milestones, Emerging Competition and Future Prospects

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "VXA-A1.1 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The report covers the drug’s...

Next Page keyboard_arrow_right